232 filings
Page 5 of 12
8-K
e4h06j
20 Feb 20
Other Events
9:12am
8-K
a4zcm
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
lvctiv40jhvh8ohr
12 Feb 20
Hepion Pharmaceuticals Announces Advancement to Third Dose Level in Ongoing Multiple
4:24pm
8-K
7o0z4
7 Feb 20
Regulation FD Disclosure
4:46pm
8-K
91016zos 07tz
28 Jan 20
Other Events
4:24pm
8-K
ciwf d6n072zmspy
9 Jan 20
Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
12:00am
8-K
8i9o6
6 Jan 20
Hepion Pharmaceuticals Announces Publication inExpert Opinion on Investigational Drugs
4:23pm
8-K
2qu6b742
11 Dec 19
Other Events
1:26pm
8-K
ogomag8d
4 Dec 19
Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments
12:00am
8-K
suki364ohf6j 5i
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
k1r8c450
20 Nov 19
Other Events
9:27pm
8-K
c5sgabmd8m3221ogw8
8 Nov 19
Hepion Pharmaceuticals to Present at The Liver MeetingÒ 2019
12:00am
8-K
3c7u35
7 Nov 19
Other Events
12:55pm
8-K
enkwh7 q4
23 Oct 19
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit
4:29pm
8-K
x5ysqsj9iy6p9tqxowa
16 Oct 19
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431’s Potential as a Treatment for Chronic Liver Diseases
4:54pm
8-K
ky4veq3wy54c auhec
10 Oct 19
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director
11:33am
8-K
jmmnrp 8h
8 Oct 19
Departure of Directors or Certain Officers
4:15pm
8-K
9myav
3 Oct 19
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions
4:20pm
8-K
g9kt2 1mu57
4 Sep 19
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
11:46am
8-K
6fdefcuv
3 Sep 19
Other Events
4:39pm